Montreal, Dec. 17, 2021 /CNW/ - The Good Shroom Co Inc.
(the "Company" or "TGSC") (TSXV: MUSH), is pleased to
announce that its wholly owned subsidiary and licensed cannabis
processor (operating as Seul CBD) has received its first purchase
order from the Société Quebecoise du Cannabis ("SQDC") for
its Nordique Royale and Velada hash brands.
TGSC's Nordique Royale and Velada hash brands will be shipped
just in time for the holidays. The first purchase order placed is
for over $100,000. The Company's hash
line will be offered at more competitive prices with the same or
higher cannabinoid content of top selling products. Comprised of 3
products to begin, the Company will offer Le Choix du Nord, a glossy and malleable
hash; Afghan Gold, a matte textured hash; and
Équilibré, a light flavoured hash with a THC:CBD ratio of
1:1. Two of which will be offered in all SQDC stores as of
December 24 and all three will be
offered on their website (www.sqdc.ca). The SQDC has advised
the Company that they expect to purchase approximately 2,500 units
per week.
The Company's CEO Eric Ronsse
stated "We are pleased with the launch of our hash products in time
for the holidays and we expect these products to quickly gain
momentum. This is the first step in a series of competitive and
innovative products which we'll be selling at the SQDC. It can be
expected that with the spread of the omicron variant and cold
weather more Quebecers will purchase their hash online where the
TGSC hash line will be available. This is another milestone in a
nationwide campaign to distribute cannabis products across the
entire country over the course of the next year."
TGSC has also received its first purchase order and a second
replenishment purchase order from the Ontario Cannabis Store for
approximately 4,000 units of its Velada cannabis beverages expected
to be delivered in January 2022. The
Company expects that the Velada cannabis beverages will also be
launched in the SQDC around the same time.
About the Company
The Good Shroom Co. operates a portfolio of brands which include
traditional cannabis and beverage products. It exists to promote
the use of functional ingredients such as probiotics and functional
mushrooms in consumer products. Its line of Teonan beverages are
first a quality and tasty beverage but also contain a dose of
functional mushrooms and probiotics.
We all have a daily routine; be it coffee, tea or another. Why
not make that routine functional for body and mind by adding
probiotics and mushrooms to it? Up to now no company has been able
to maintain a familiar taste at a fair price while making them
truly functional. The Good Shroom Co has bridged that gap and
intends on making its brands household names for making it a part
of its customers daily routine.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
Cautionary Note Regarding Forward-Looking
Information
This press release contains statements which constitute
"forward-looking statements" and "forward-looking information"
within the meaning of applicable securities laws, including
statements regarding the plans, intentions, beliefs and current
expectations of the Corporation with respect to future business
activities and sales, including the anticipated orders to be placed
by the SQDC. Forward-looking statements are often identified by the
words "may", "would", "could", "should", "will", "intend", "plan",
"anticipate", "believe", "estimate", "expect" or similar
expressions. Investors are cautioned that forward-looking
statements are not based on historical facts but instead reflect
the Corporation's expectations, estimates or projections concerning
future results or events based on the opinions, assumptions and
estimates of management considered reasonable at the date the
statements are made. Although the Corporation believes that the
expectations reflected in such forward-looking statements are
reasonable, such statements involve risks and uncertainties, and
undue reliance should not be placed thereon, as unknown or
unpredictable factors could have material adverse effects on future
results, performance or achievements. Among the key factors that
could cause actual results to differ materially from those
projected are the following: market acceptance of the
Company's hash and other cannabis products, changes in the vendor's
business or strategy, changes in our supplier's operations and
pricing, expectations regarding competition and their pricing
strategy; maintaining in good standing all necessary regulatory
licenses and authorizations for its products; the benefits, safety,
efficacy, dosing and social acceptance of cannabis related products
and no material changes in the legal environment; changes in
applicable laws and regulations compliance with extensive
government regulation; operational risks related to and COVID-19 or
other pandemic and supply chain disruptions and shortages.
Should one or more of these risks or uncertainties materialize, or
should assumptions underlying the forward-looking statements prove
incorrect, actual results may vary materially from those described
herein as intended, planned, anticipated, believed, estimated or
expected. Although the Company has attempted to identify important
risks, uncertainties and factors which could cause actual results
to differ materially, there may be others that cause results not to
be as anticipated, estimated or intended and such changes could be
material. The Company does not intend, and do not assume any
obligation, to update the forward-looking statements except as
otherwise required by applicable law. Trading in the
securities of the Company should be considered highly
speculative.
SOURCE The Good Shroom Co Inc.
